MRNA Cash Flow Statement
Moderna Inc - Operating, Investing & Free Cash Flow Analysis
Operating Cash Flow
($1.87B)
Free Cash Flow
($1.68B)
FCF per Share
-
-8.03% yield
CapEx
$192.00M
Operating Activities
Cash generated from core business operations
Primary cash generation
Investing Activities
Cash used for investments and capital expenditures
Total investing activities
Financing Activities
Cash from financing activities including debt, equity, and dividends
Total financing activities
Free Cash Flow (FCF) Calculation
Cash Flow Trends (Annual)
| Period | Operating CF | Investing CF | Financing CF | Free CF |
|---|---|---|---|---|
| 2025-12-31 | ($1.87B) | $1.95B | $593.00M | ($1.68B) |
| 2024-12-31 | ($3.00B) | $1.95B | $56.00M | - |
| 2024-12-31 | ($3.00B) | $1.95B | $56.00M | ($1.95B) |
| 2023-12-31 | ($3.12B) | $4.21B | ($1.38B) | - |
| 2023-12-31 | ($3.12B) | $4.21B | ($1.38B) | ($2.41B) |
View Complete Financial Analysis
Full income statements, balance sheets, and detailed cash flow analysis
Open Full AnalysisFrequently Asked Questions
What is MRNA free cash flow?
MRNA's most recent free cash flow (FCF) is ($1.68B). Free cash flow represents the cash a company generates after accounting for capital expenditures, and is available for dividends, buybacks, or debt reduction.
What is MRNA operating cash flow?
MRNA generated ($1.87B) in operating cash flow in the most recent period. Operating cash flow shows the cash generated from core business operations.
What is MRNA FCF per share?
FCF per share can be calculated by dividing free cash flow by shares outstanding.
Is MRNA cash flow growing?
MRNA's operating cash flow grew by 37.6% year-over-year.
What is MRNA FCF yield?
MRNA has a free cash flow yield of -8.03%, calculated as free cash flow divided by market capitalization. A higher FCF yield may indicate better value.
What is MRNA capital expenditure?
MRNA spent $192.00M on capital expenditures (CapEx) in the most recent period. CapEx represents investments in property, plant, and equipment.